Suppr超能文献

干细胞特性为人类结直肠癌所有步骤提供基础,定义了有效治疗策略的核心。

Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies.

机构信息

StemGen SpA, Milan, Italy.

Fondazione IRCCS Casa Sollievo della Sofferenza, Cancer Stem Cells Unit, ISBReMIT, Foggia, Italy.

出版信息

EBioMedicine. 2019 Jun;44:346-360. doi: 10.1016/j.ebiom.2019.04.049. Epub 2019 May 2.

Abstract

BACKGROUND

Despite their lethality and ensuing clinical and therapeutic relevance, circulating tumor cells (CTCs) from colorectal carcinoma (CRC) remain elusive, poorly characterized biological entities.

METHODS AND FINDINGS

We perfected a cell system of stable, primary lines from human CRC showing that they possess the full complement of ex- and in-vivo, in xenogeneic models, characteristics of CRC stem cells (CCSCs). Here we show how tumor-initiating, CCSCs cells can establish faithful orthotopic phenocopies of the original disease, which contain cells that spread into the circulatory system. While in the vascular bed, these cells retain stemness, thus qualifying as circulating CCSCs (cCCSCs). This is followed by the establishment of lesions in distant organs, which also contain resident metastatic CCSCs (mCCSCs).

INTERPRETATION

Our results support the concept that throughout all the stages of CRC, stemness is retained as a continuous property by some of their tumor cells. Importantly, we describe a useful standardized model that can enable isolation and stable perpetuation of human CRC's CCSCs, cCCSCs and mCCSCs, providing a useful platform for studies of CRC initiation and progression that is suitable for the discovery of reliable stage-specific biomarkers and the refinement of new patient-tailored therapies. FUND: This work was financially supported by grants from "Ministero della Salute Italiano"(GR-2011-02351534, RC1703IC36 and RC1803IC35) to Elena Binda and from "Associazione Italiana Cancro" (IG-14368) Angelo L. Vescovi. None of the above funders have any role in study design, data collection, data analysis, interpretation, writing the project.

摘要

背景

尽管结直肠癌(CRC)的循环肿瘤细胞(CTC)具有致命性,并具有重要的临床和治疗意义,但它们仍然难以捉摸,是特征描述较差的生物实体。

方法和发现

我们完善了一个来自人类 CRC 的稳定原代细胞系统,该系统表明它们具有完整的 CRC 干细胞(CCSCs)的体外和体内特性以及异种移植模型中的特性。在这里,我们展示了肿瘤起始的 CCSC 细胞如何建立与原始疾病忠实的原位表型,其中包含扩散到循环系统的细胞。在血管床中,这些细胞保持干细胞特性,因此有资格成为循环 CCSC(cCCSC)。随后,在远处器官中建立病变,其中也包含常驻转移性 CCSC(mCCSC)。

解释

我们的结果支持这样的概念,即在 CRC 的所有阶段,一些肿瘤细胞都保持着干细胞特性。重要的是,我们描述了一个有用的标准化模型,可以实现人类 CRC 的 CCSC、cCCSC 和 mCCSC 的分离和稳定维持,为 CRC 的起始和进展研究提供了一个有用的平台,适合发现可靠的阶段特异性生物标志物和改进新的针对患者的治疗方法。

资金

这项工作得到了意大利卫生部(GR-2011-02351534、RC1703IC36 和 RC1803IC35)授予 Elena Binda 和意大利癌症协会(IG-14368)授予 Angelo L. Vescovi 的资助。上述资助者均在研究设计、数据收集、数据分析、解释和项目撰写方面没有任何作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验